Structure-Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017-Present).

Èandor, Alexandru; IonuÈ, Ioana; Marc, Gabriel; Oniga, Ilioara; Eniu, Dan; Oniga, Ovidiu

Èandor, Alexandru; IonuÈ, Ioana; Marc, Gabriel; Oniga, Ilioara; Eniu, Dan; Oniga, Ovidiu.

Afiliación

Èandor A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu HaÈieganu" University of Medicine and Pharmacy, 41 Victor BabeÈ Street, 400010 Cluj-Napoca, Romania.
IonuÈ I; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu HaÈieganu" University of Medicine and Pharmacy, 41 Victor BabeÈ Street, 400010 Cluj-Napoca, Romania.
Marc G; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu HaÈieganu" University of Medicine and Pharmacy, 41 Victor BabeÈ Street, 400010 Cluj-Napoca, Romania.
Oniga I; Department of Pharmacognosy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 12 Ion Creanga Street, 400010 Cluj-Napoca, Romania.
Eniu D; Department of Surgical Oncology, "Iuliu HaÈieganu" University of Medicine and Pharmacy, 34-36 Republicii Street, 40015 Cluj-Napoca, Romania.
Oniga O; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu HaÈieganu" University of Medicine and Pharmacy, 41 Victor BabeÈ Street, 400010 Cluj-Napoca, Romania.

Pharmaceuticals (Basel) ; 16(4)2023 Apr 03.

Article en En | MEDLINE | ID: mdl-37111291

Palabras clave

4-anilino-quinazoline; EGFR; allosteric inhibitor; competitive inhibitor; covalent inhibitor; quinazoline; structureactivity relationship

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google